Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that ...

Whether its working with pharmaceutical, CRO, biotech organisations & medical communications agencies covering Clinical Research, Regulatory Affairs, Biometrics, Pharmacovigilance, Medical Affairs and ...

LONDON--(BUSINESS WIRE)--The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and ...

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a global scale. We also syndicate our video library in ...

Helping organisations to meet their communications challenges. We bring together the best teams to deliver fantastic outcomes for our clients.

Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some ...

We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we ...

How good are your sales people at selling and how do you know? Sales interAction are UK based, with a global reach focusing on In Call Excellence Our web-based tool Advance® enables sales people to ...

Ig-Innovations Ltd is a brand new company with over 30 years experience in antibody production and immunoassay development. Confusing but true – the experience and expertise is in the people we employ ...

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster.

Pfizer’s anti-tissue factor pathway inhibitor Hympavzi (marstacimab-hncq) has been approved by the US Food and Drug ...

Johnson & Johnson’s (J&J) investigational FcRn blocker nipocalimab has demonstrated sustained disease control in adolescents with the rare autoimmune disease generalised myasthenia gravis (gMG), ...